531results about How to "Safety management" patented technology

A method is provided for treating a subject, including applying a current to a site of the subject selected from the list consisting of: a vagus nerve of the subject, an epicardial fat pad of the subject, a pulmonary vein of the subject, a carotid artery of the subject, a carotid sinus of the subject, a vena cava vein of the subject, and an internal jugular vein of the subject. The method also includes configuring the current so as to treat a condition of the subject selected from the list consisting of: an autoimmune disease, an autoimmune inflammatory disease, multiple sclerosis, encephalitis, myelitis, immune-mediated neuropathy, myositis, dermatomyositis, polymyositis, inclusion body myositis, inflammatory demyelinating polyradiculoneuropathy, Guillain Barre syndrome, myasthenia gravis, inflammation of the nervous system, inflammatory bowel disease, Crohn's disease, ulcerative colitis, SLE (systemic lupus erythematosus), rheumatoid arthritis, vasculitis, polyarteritis nodosa, Sjogren syndrome, mixed connective tissue disease, glomerulonephritis, thyroid autoimmune disease, sepsis, meningitis, a bacterial infection, a viral infection, a fungal infection, sarcoidosis, hepatitis, and portal vein hypertension.

A method and apparatus for reducing the workload of titrating drug to effect while leaving clinician users in control of a related procedure is described. A drug delivery device is controlled to achieve a target drug concentration at a selected site in the patient or a predetermined infusion rate waveform. The time profile of the target drug concentration or a predetermined infusion rate waveform is controlled by a drug state model that uses clinical heuristics to implement safe, pre-defined changes in the target drug concentration or infusion rate and user-commanded changes in target drug concentration or infusion rate. The invention allows time to assess the response of the patient to changes in drug level by making small incremental and conservative changes in drug level over time.

A mobile terminal including a communication unit configured to communicate with at least one external terminal; a memory configured to store at least a first and second operating system including at least first and second modes, respectively; and a controller configured to execute the first operating system and to activate the first mode corresponding to the first operating system, to display a first information screen on a display unit corresponding to the activated first mode, to receive a switching signal indicating the first mode is to be switched to the second mode, to perform an authentication procedure for authenticating that the first mode can be switched to the second mode, to activate the second mode and deactivate the first mode when the authentication procedure is validly performed, and to display a second information screen on the display unit corresponding to the second mode and that is different than the first information screen.

A voice control system for managing home electrical appliances includes a home agent server (HAS) connected to the home electrical appliances, a microphone and a speaker linked to the agent server through an in-house network. An transaction processing (TP) program runs on HAS and interprets the user's voice request to find a destined appliance and a manner of control the same, and performs the requested control to the destined appliance. The result is notified to the user by means of a voice message.

A voice control system for managing home electrical appliances includes a home agent server (HAS) connected to the home electrical appliances, a microphone and a speaker linked to the agent server through an in-house network. An transaction processing (TP) program runs on HAS and interprets the user's voice request to find a destined appliance and a manner of control the same, and performs the requested control to the destined appliance. The result is notified to the user by means of a voice message.

A mobile terminal including a communication unit configured to communicate with at least one external terminal; a memory configured to store at least first and second operating systems including at least first and second modes, respectively; and a controller configured to execute the first operating system and to activate the first mode corresponding to the first operating system, to display a first information screen on a display unit corresponding to the activated first mode, to receive a switching signal indicating the first mode is to be switched to the second mode, to attempt to switch to the second mode based on the received switching signal, and to restrict a specific application executing in the first mode when the second mode is not switched to.

A mobile terminal including a communication unit configured to communicate with at least one external terminal; a memory configure to store at least first and second operating systems including at least first and second modes, respectively; and a controller configured to execute the first operating system and to activate the first mode corresponding to the first operating system, to display a first information screen on a display unit corresponding to the activated first mode, to receive a switching signal indicating the first mode is to be switched to the second mode, to activate the second mode and deactivate the first mode, and to display a second information screen on the display unit corresponding to the second mode and that is different than the first information screen.

The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.

A method of security management of a wireless mobile device interoperating with a network switching center (NSC) is provided, and an apparatus using the method. The method includes respectively managing a traffic map by each service-level, wherein wireless mobile devices frequently communicating with other wireless mobile devices are grouped and stored as a group, among wireless mobile devices on a network, detecting a wireless mobile device determined to be associated with at least any one of a security attack and a malicious code by analyzing data traffic received from a network switching center, and isolating up to all wireless mobile devices within the group in which the detected wireless mobile device is included, from the network by referring to the traffic map.

Techniques for managing and protecting computing environments are disclosed. A safe computing environment can be provided for ensuring the safety and / or management of a device. The safe computing environment can be secured by a safe component that isolates and protects it from unsafe computing environments which may also be operating. As a result, various security and management activities can be securely performed from a safe computing environment. A safe computing environment can, for example, be provided on a device as a safe virtual computing environment (e.g., a safe virtual machine) protected by a safe virtual computing monitor (e.g., a safe virtual machine monitor) from one or more other virtual computing environments that are not known or not believed to be safe for the device. It will also be appreciated that the safe components can, for example, be provided as trusted components for a device. As such, various trusted components (or agent) can operate in a trusted computing environment secured from interference by components that many not be trusted and perform various security and / or management tasks alone or in connection, for example, with other trusted components (e.g., trusted serves).

An improved injection site (12) for infusion of parenteral fluids and the like is provided, having a pressure-actuated valve (20) and a novel split septum unit (24), which effectively prevent reflux of blood into the assembly (10). The septum unit (24) includes a resilient split septum body (64) which is precompressed so that the septum body (64) is caused to protrude proximally (78) upon insertion of a cannula (16). Consequently, upon removal of the cannula (16), there is essentially no “drumming” or creation of friction-induced negative pressures sufficient to generate blood reflux. The preloaded septum body (64) also has its proximal surface (74) essentially flush and coplanar with the adjacent proximal end (66b) of the tubular septum holder (66) to enhance the cleanliness of the unit (24). The specialized well (46) and septum unit (24) afford a resilient seal between the periphery of the septum body (64) and the surface (50), and a separate hard-surface seal between the outer margin of the surface (50) and the septum holder (66).

A system and method facilitating secure credential management is provided. An aspect of the present invention provides for a credential management system including a credential user interface component, a trusted proxy component and a secure user interface component. The system can facilitate the secure acquisition, storage and / or application of credential(s) for a user (e.g., when accessing a particular resource) through a secure, isolated environment. For example, the system can be a core building block for operating system component(s) and / or application(s) that handle credential(s) in a secure manner.

A care system and associated methods are provided for alleviating patient pain, anxiety and discomfort associated with medical or surgical procedures, the system comprising: at least one patient health monitor device coupled to a patient and generating a signal reflecting at least one physiological condition of the patient; a drug delivery controller supplying one or more drugs to the patient; a memory device storing a safety data set reflecting parameters of the at least one patient physiological condition; and an electronic controller interconnected between the patient health monitor, the drug delivery controller and the safety data set; wherein said electronic controller manages the application of the drugs in accord with the safety data set. In another aspect of the invention, the care system facilitates a procedural physician's safely and efficaciously providing conscious sedation to a patient by additionally providing a consciousness monitoring-system which monitors the consciousness of the patient and generates a value representing the level of patient consciousness. Methods for alleviating patient pain and anxiety in accordance with the invention comprise connecting a drug delivery device to a patient, such device having a drug delivery controller supplying one or more drugs and being coupled to an electronic controller; attaching at least one patient health monitor device to the patient; accessing a memory device which stores a safety data set reflecting parameters of at least one patient physiological condition; and delivering the drugs to the patient in accord with the safety data set. In further aspects of the invention, the consciousness monitoring system is an automated consciousness monitoring system which includes patient query and response devices. Additional embodiments of the system and methods are directed to alleviating patient pain or discomfort while enabling safe patient controlled drug delivery in correlation with the monitoring of patient health conditions.

The present invention discloses an alpha-glucosidase inhibitor for prevention of transition from high-risk IGT to diabetes mellitus, for prophylaxis of diabetes mellitus, as well as for treating high-risk IGT.

The invention discloses an identity and access control and management system and method in a cloud environment. The system comprises an identity and access control and management system (IAM), a user terminal and an application server. For different application services, integrated identity authentication and unified user management follow an identity authentication and access control separation principle, and user identity and access control management is realized. On the respect of user identity information management, from generation to cancellation of the user identity, a registration service provides self-help service for the user; on the respect of user authentication, a double-factor authentication technology is used for realizing the bidirectional authentication of the user and an authentication server and issuing an authentication bill to realize one-time authentication and multi-time use; and on the respect of access control and management, the access authority of the user is managed based on a role access control strategy of a user group, and the server is authorized to issue an authorized bill to the user. By adopting the identity and access control and management system and method disclosed by the invention, the user is convenient to manage the identity information, multi-time authentication is avoided, the authentication security is enhanced, and the illegal access of unauthorized users is prevented.

A mobile telephone terminal (1) comprises an address book table (TLA) that stores an address book indicative of the names and telephone numbers or e-mail addresses of the other ends of communication; a secret address book table (TLB) that generates a plurality of secret letter sequences, in which a part or all of the letters of the names and telephone numbers or e-mail addresses of the other ends of communication are concealed, and that stores the generated plurality of secret letter sequences; and an address book displaying part (104) that displays, based on the address book table (TLA), the name and telephone number or e-mail address of the other end of communication designated by a user without concealing the letters in a real name display mode, and that displays, based on the secret address book table (TLB), a secret letter sequence, in which a part or all of the letters of the name and telephone number or e-mail address of the other end of communication designated by the user is concealed, in an anonymity display mode.

A method is provided for treating a subject, including applying a current to a site of the subject selected from the list consisting of: a vagus nerve of the subject, an epicardial fat pad of the subject, a pulmonary vein of the subject, a carotid artery of the subject, a carotid sinus of the subject, a vena cava vein of the subject, and an internal jugular vein of the subject. The method also includes configuring the current so as to treat a condition of the subject selected from the list consisting of: an autoimmune disease, an autoimmune inflammatory disease, multiple sclerosis, encephalitis, myelitis, immune-mediated neuropathy, myositis, dermatomyositis, polymyositis, inclusion body myositis, inflammatory demyelinating polyradiculoneuropathy, Guillain Barre syndrome, myasthenia gravis, inflammation of the nervous system, inflammatory bowel disease, Crohn's disease, ulcerative colitis, SLE (systemic lupus erythematosus), rheumatoid arthritis, vasculitis, polyarteritis nodosa, Sjogren syndrome, mixed connective tissue disease, glomerulonephritis, thyroid autoimmune disease, sepsis, meningitis, a bacterial infection, a viral infection, a fungal infection, sarcoidosis, hepatitis, and portal vein hypertension.

In a microprocessor that internally has a microprocessor specific secret key, a key management unit is provided to carry out a key registration for reading out from an external memory a distribution key that is obtained in advance by encrypting the instruction key by using a public key corresponding to the secret key, decrypting the distribution key by using the secret key to obtain the instruction key, and registering the instruction key in correspondence to a specific program identifier for identifying the program into a key table, and to notify a completion of the key registration to the processor core asynchronously by interruption when the key registration is completed.

A system, program product and method for automatically adjusting the traffic light of a traffic light controlled intersection. Personal data relative to a pedestrian cross walking the intersection, including walking speed, and the current speed of a vehicle approaching the intersection are simultaneously acquired. Both the personal data and the vehicle current speed are processed to generate cross walk control signals, such as indicators of risk of collision between vehicle and pedestrian. Where the risk warrants action, the “stop” condition of the traffic light is enable to warn the vehicle to stop. Traffic control signals are also generated to control the duration of the “walk” condition for slow moving pedestrians.

A care system and associated methods are provided for alleviating patient pain, anxiety and discomfort associated with medical or surgical procedures, the system comprising: at least one patient health monitor device coupled to a patient and generating a signal reflecting at least one physiological condition of the patient; a drug delivery controller supplying one or more drugs to the patient; a memory device storing a safety data set reflecting parameters of the at least one patient physiological condition; and an electronic controller interconnected between the patient health monitor, the drug delivery controller and the safety data set; wherein said electronic controller manages the application of the drugs in accord with the safety data set. In another aspect of the invention, the care system facilitates a procedural physician's safely and efficaciously providing conscious sedation to a patient by additionally providing a consciousness monitoring system which monitors the consciousness of the patient and generates a value representing the level of patient consciousness. Methods for alleviating patient pain and anxiety in accordance with the invention comprise connecting a drug delivery device to a patient, such device having a drug delivery controller supplying one or more drugs and being coupled to an electronic controller; attaching at least one patient health monitor device to the patient; accessing a memory device which stores a safety data set reflecting parameters of at least one patient physiological condition; and delivering the drugs to the patient in accord with the safety data set. In further aspects of the invention, the consciousness monitoring system is an automated consciousness monitoring system which includes patient query and response devices. Additional embodiments of the system and methods are directed to alleviating patient pain or discomfort while enabling safe patient controlled drug delivery in correlation with the monitoring of patient health conditions.

A care system and associated methods are provided for alleviating patient pain, anxiety and discomfort associated with medical or surgical procedures. The care system facilitates a procedural clinician's safely and efficaciously providing sedation and analgesia and in some measure, amnesia to a patient by providing a responsiveness monitoring system which monitors the responsiveness of the patient and generates a value representing the level of patient responsiveness. In further aspects of the invention, the responsiveness monitoring system is an automated system which includes patient query and response devices. Additional embodiments of the system and methods are directed to alleviating patient pain or discomfort while enabling safe drug delivery (automated, clinician-controlled or patient-controlled) in correlation with the monitoring of patient health conditions.

A care system and associated methods are provided for alleviating patient pain, anxiety and discomfort associated with medical or surgical procedures. The system comprises: at least one patient health monitor device coupled to a patient and generating a signal reflecting at least one physiological condition of the patient; a drug delivery controller supplying one or more drugs to the patient; a memory device storing a safety data set reflecting parameters of at least one patient physiological condition; and an electronic controller interconnected between the patient health monitor, the drug delivery controller and the safety data set. The electronic controller is capable of effecting a change in the drug supply delivered to the patient and the generation of current signals by the patient health monitor device depending on a comparison between at least one patient physiological condition at its corresponding value reflected in the safety data set.

The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.

A game or other software program is made accessible for execution by clients on a peer-peer network only after a plurality of verifications are made to ensure that control of the software is maintained. With a request sent to a server to access the software, a client includes a nonce and an ID of the user. The server digitally signs a portion of a ticket that is returned to the client, which includes the nonce, a time stamp, and the ID. The ticket is required to access the software. The clients are required to exchange the tickets, verify the digital signature on the portion of each ticket, and use the information therein to confirm that the tickets are current, issued by the correct server, issued to the proper users, and received from the users who are intended to execute the software.

A melanin-concentrating hormone antagonist comprising a compound of the formula: wherein R is hydrogen atom or a cyclic group which may be substituted; X is a bond or a spacer having a main chain of 1 to 10 atoms; Y is a spacer having a main chain of 1 to 6 atoms; ring A is benzene ring which may be further substituted; ring B is a 5- to 9-membered nitrogen-containing non-aromatic heterocyclic ring which may be further substituted; R1 and R2 are the same or different and are hydrogen atom, a hydrocarbon group which may be substituted or a heterocyclic group which may be substituted; or R1 and R2, together with the adjacent nitrogen atom, may form a nitrogen-containing heterocyclic ring which may be substituted; or R2, together with the adjacent nitrogen atom and Y, may form a nitrogen-containing heterocyclic ring which may be substituted; or a salt thereof is useful as a preventive or therapeutic agent for obesity, etc.

An apparatus and method for delivery of medication is provided. The invention includes a system for organizing and storing pre-determined dosages of medication by matching indicia on both the storage apparatus and the apparatus containing the medication. The invention allows visually-impaired, elderly, or those unable to read conventional indicia to determine the appropriate dosage of medication and to safely select and take the medication in the appropriate pre-determined dosage indicated by the indicia on the storage apparatus matching the indicia on the apparatus containing the medication.

A system and method facilitating secure credential management is provided. An aspect of the present invention provides for a credential management system including a credential user interface component, a trusted proxy component and a secure user interface component. The system can facilitate the secure acquisition, storage and / or application of credential(s) for a user (e.g., when accessing a particular resource) through a secure, isolated environment. For example, the system can be a core building block for operating system component(s) and / or application(s) that handle credential(s) in a secure manner.

Upon receipt of a service data request from a client, a license server offering a key to decrypt a content transmits a user information request to the client. On receiving the user information request, the client displays a message prompting its user to enter such user information as the user's personal information and accounting information. The user information thus entered is sent from the client to the license server. On receiving the user information, the license server assigns a leaf of a key-managed hierarchical tree structure to the client, generates a set of node keys as a device node key, sends to the client the device node key together with a leaf ID and a private key of the client in question, and records the user information in correspondence with the leaf ID.